D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 2.46 THB -1.6% Market Closed
Market Cap: 1.1B THB
Have any thoughts about
DOD Biotech PCL?
Write Note

Balance Sheet

Balance Sheet Decomposition
DOD Biotech PCL

Current Assets 471.9m
Cash & Short-Term Investments 75.7m
Receivables 74.2m
Other Current Assets 321.9m
Non-Current Assets 731.8m
Long-Term Investments 2.6m
PP&E 572.6m
Intangibles 46.9m
Other Non-Current Assets 109.7m
Current Liabilities 242.1m
Accounts Payable 99.5m
Short-Term Debt 87.1m
Other Current Liabilities 55.6m
Non-Current Liabilities 74.6m
Long-Term Debt 51.9m
Other Non-Current Liabilities 22.8m

Balance Sheet
DOD Biotech PCL

Rotate your device to view
Balance Sheet
Currency: THB
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
22
78
47
112
137
82
143
162
30
Cash
22
78
47
112
137
82
143
162
30
Short-Term Investments
0
0
0
5
300
0
0
0
0
Total Receivables
7
40
40
51
64
216
271
337
57
Accounts Receivables
7
40
40
51
63
216
263
315
39
Other Receivables
0
0
0
0
0
0
8
22
18
Inventory
85
49
21
23
25
115
246
113
98
Other Current Assets
59
18
15
7
9
27
13
13
12
Total Current Assets
173
185
123
198
534
440
673
626
197
PP&E Net
14
100
233
250
302
861
922
967
976
PP&E Gross
14
100
233
250
302
861
922
967
976
Accumulated Depreciation
3
7
15
33
53
96
159
253
301
Intangible Assets
0
0
1
1
1
28
11
6
6
Goodwill
0
0
0
0
0
108
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
401
120
106
3
3
Other Long-Term Assets
0
0
12
5
169
17
45
25
110
Other Assets
0
0
0
0
0
108
0
0
0
Total Assets
187
N/A
285
+52%
370
+30%
454
+23%
1 407
+210%
1 575
+12%
1 758
+12%
1 627
-7%
1 291
-21%
Liabilities
Accounts Payable
52
13
10
20
7
83
181
93
80
Accrued Liabilities
4
8
8
17
6
23
32
14
17
Short-Term Debt
0
0
0
0
10
93
130
77
149
Current Portion of Long-Term Debt
0
3
10
10
1
50
48
34
22
Other Current Liabilities
17
19
35
70
192
38
77
42
35
Total Current Liabilities
72
43
63
117
216
289
468
259
304
Long-Term Debt
20
16
41
43
1
33
27
73
58
Deferred Income Tax
0
0
0
0
0
5
24
12
11
Minority Interest
0
0
0
0
0
19
11
18
6
Other Liabilities
0
2
4
5
5
10
13
21
25
Total Liabilities
92
N/A
61
-34%
108
+77%
165
+53%
222
+35%
355
+60%
544
+53%
346
-36%
404
+17%
Equity
Common Stock
50
90
150
150
205
205
205
205
205
Retained Earnings
45
134
112
140
38
143
69
185
209
Additional Paid In Capital
0
0
0
0
940
940
940
891
891
Unrealized Security Profit/Loss
0
0
0
0
1
69
0
0
0
Total Equity
95
N/A
224
+136%
262
+17%
290
+10%
1 184
+309%
1 219
+3%
1 214
0%
1 281
+5%
887
-31%
Total Liabilities & Equity
187
N/A
285
+52%
370
+30%
454
+23%
1 407
+210%
1 575
+12%
1 758
+12%
1 627
-7%
1 291
-21%
Shares Outstanding
Common Shares Outstanding
100
180
300
300
410
410
411
411
411

See Also

Discover More